DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR

Código QR

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR

.

Guardado en:

Detalles Bibliográficos
Autores principales:	D. A. Mezhenskaia, T. S. Кotomina, I. N. Isakova-Sivak, V. A. Matyushenko, A. S. Evsina, M. C. Kim, S. M. Kang, L. G. Rudenko
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/da5973d393aa414a99c60df1c59069fb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection
por: Daria Mezhenskaya, et al.
Publicado: (2021)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Andrew Chak-Yiu Lee, et al.
Publicado: (2021)

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
por: Anthony C. Marriott, et al.
Publicado: (2021)

Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine
por: Wouter A. A. de Steenhuijsen Piters, et al.
Publicado: (2019)

Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
por: Pui Wang, et al.
Publicado: (2019)

AVIDITY EVALUATION OF LOCAL IgA ANTIBODIES IN PERSONS IMMUNIZED WITH LIVE INFLUENZA VACCINE
por: S. A. Donina, et al.
Publicado: (2014)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Raveen Rathnasinghe, et al.
Publicado: (2021)

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
por: Jasmina M. Luczo, et al.
Publicado: (2021)

EVALUATION OF T CELL IMMUNOLOGICAL MEMORY BY MEANS OF CD45+ EXPRESSION IN HUMANS VACCINATED WITH LIVE REASSORTANT INFLUENZA VACCINE
por: A. N. Naikhin, et al.
Publicado: (2014)

OMOLOGICAL AND HETEROLOGICAL ANTIBODY AND T CELL IMMUNE RESPONSES TO LIVE ATTENUATED INFLUENZA VACCINE A (H5N2) AND A (H7N3)
por: A. N. Naykhin, et al.
Publicado: (2015)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
por: I. V. Losev, et al.
Publicado: (2017)

LIVE ATTENUATED VACCINES FOR THE IMMUNOPROPHYLAXIS
por: O. A. Shamsutdinova
Publicado: (2017)

Effectiveness of the Pigeon Pox Vaccine on the Chicken Vaccinated With Avian Influenza Vaccine
por: Christine A. Mikhael, et al.
Publicado: (2019)

Serological response to influenza vaccination among children vaccinated for multiple influenza seasons.
por: Sajjad Rafiq, et al.
Publicado: (2012)

Defining the root cause of reduced H1N1 live attenuated influenza vaccine effectiveness: low viral fitness leads to inter-strain competition
por: Oliver Dibben, et al.
Publicado: (2021)

Detection Limits Of Live Attenuated Poultry Viral Vaccine Testing Method For Detection Of Bacterial Contamination
por: Hanan M. Ibrahim, et al.
Publicado: (2019)

Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season
por: Chiara Gasparini, et al.
Publicado: (2021)

LOCAL ANTIBODY AND CELLULAR IMMUNE RESPONSES TO INFLUENZA INFECTION AND VACCINATION
por: G. D. Petukhova, et al.
Publicado: (2014)

IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
por: M. P. Kostinov, et al.
Publicado: (2017)

Accounting for the spread of vaccination behavior to optimize influenza vaccination programs.
por: Dor Kahana, et al.
Publicado: (2021)

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
por: M. K. Erofeeva, et al.
Publicado: (2014)

Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
por: Bo Ryoung Park, et al.
Publicado: (2021)

Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines
por: Mohamed Ahmed Attia, et al.
Publicado: (2021)

Reply to “No Clinical Association of Live Attenuated Influenza Vaccine with Nasal Carriage of Bacteria or Acute Otitis Media”: Specific Recommendations for Future Studies
por: Michael J. Mina, et al.
Publicado: (2014)

Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells
por: Li-Meng Yan, et al.
Publicado: (2020)

Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine
por: L. M. Tsybalova, et al.
Publicado: (2019)

A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
por: Yingyun Cai, et al.
Publicado: (2020)

Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains
por: Ewan P. Plant, et al.
Publicado: (2017)

Microneutralization reaction compared to hemagglutination inhibition assay to evaluate immunogenicity of influenza vaccines and influenza diagnostics
por: V. Z. Krivitskaya, et al.
Publicado: (2020)

Simultaneous Infection With Porcine Reproductive and Respiratory Syndrome and Influenza Viruses Abrogates Clinical Protection Induced by Live Attenuated Porcine Reproductive and Respiratory Syndrome Vaccination
por: Tiphany Chrun, et al.
Publicado: (2021)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
por: Sarah Creytens, et al.
Publicado: (2021)

The Usage of Influenza Vaccine to Prevent Seasonal Influenza during Pandemic COVID-19
por: Yelvi Levani, et al.
Publicado: (2021)

Influenza vaccination and prognosis for patients with high cardiovascular risk
por: Olga A. Dmitrieva, et al.
Publicado: (2021)

Optimal vaccine allocation for the early mitigation of pandemic influenza.
por: Laura Matrajt, et al.
Publicado: (2013)

Serological Responses to Influenza Vaccination during Pregnancy
por: Ana Vazquez-Pagan, et al.
Publicado: (2021)

School-based influenza vaccination: parents' perspectives.
por: Candace Lind, et al.
Publicado: (2014)

CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
por: I. B. Esmagambetov, et al.
Publicado: (2016)

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination
por: Erik A. Karlsson, et al.
Publicado: (2016)

Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
por: Subir Karmakar, et al.
Publicado: (2021)